![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 545445-44-1
2. 5,6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1h)-pyridinone
3. 5-morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-2,3-dihydropyridin-6-one
4. 3-morpholin-4-yl-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydro-1h-pyridin-2-one
5. 3-morpholino-1-[4-(2-oxo-1-piperidyl)phenyl]-5,6-dihydropyridin-2(1h)-one
6. Mfcd19440881
7. 3-morpholino-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin-2(1h)-one
8. 5,6-dihydro-3-(4-morpholinyl)-1-(4-(2-oxo-1-piperidinyl)phenyl)-2(1h)-pyridinone
9. Schembl5444324
10. Dtxsid60625157
11. Bcp08521
12. Cs-m1107
13. Akos015998979
14. Zinc100012387
15. 3-morpholino-1-(4-(2-oxopiperidin-1-
16. Ac-26422
17. As-18408
18. Da-16986
19. Sy045772
20. Yl)phenyl)-5,6-dihydropyridin-2(1h)-one
21. Am20090740
22. Ft-0686945
23. F11752
24. A850071
25. 2(1h)-pyridinone, 5,6-dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-
26. 3-(morpholin-4-yl)-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin-2(1h)-one
27. 3-morpholin-4-yl-1-[4-(2-oxo-piperidin-1-yl)-phenyl]-5,6-dihydro-1h-pyridin-2-one
28. 3-morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydro Pyridin-2(1h)-one
Molecular Weight | 355.4 g/mol |
---|---|
Molecular Formula | C20H25N3O3 |
XLogP3 | 1.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 355.18959167 g/mol |
Monoisotopic Mass | 355.18959167 g/mol |
Topological Polar Surface Area | 53.1 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 563 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.